13F-NT filed by Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. filed this 13F-NT for the quarter ended 2023-03-31, filed 2023-04-28.
- Accession
- 0001104659-23-051913
- Filer
- CIK 1615258
- Filed
- 2023-04-28
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A notice, 13F file number 028-18303. A notice: the holdings are in another manager's report. The resolved quarter.
Other managers
- reports for this filerFosun International Ltd028-15992
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-NT 0001104659-23-051913 | this filing | 2023-04-28 | acceptance time not in the bulk data set |